About: http://data.cimple.eu/news-article/3dad596c0842e22b8ef6b585a820b1b01a4b97920786715ffaf06ce5

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/3dad596c0842e22b8ef6b585a820b1b01a4b97920786715ffaf06ce5 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	China has a fifth potential coronavirus vaccine in a human trial and more are on the way, a health official said Friday, as the world races to find a formula to stop the contagion in its tracks. So far there have been no "major adverse reactions" reported among the 2,575 volunteers participating in the five phase-two tests, said Zeng Yixin, deputy director of the National Health Commission. "According to the plan, if all goes well, the above projects will complete the second phase of clinical trials in July this year," Zeng said. More vaccine candidates are in the pipeline and awaiting approval for human trials, he added. China had previously said four human trials for possible vaccines were under way. Zeng did not say when the trials, which must complete three phases for the drug to be approved for use, might be finished. Scientists around the world are working at breakneck speed to develop a vaccine for COVID-19, the disease caused by the virus, which has killed more than 300,000 people and infected over 4.4 million. But China's success in largely taming the outbreak could pose a hurdle for its vaccine developers when they reach the final stage of testing. The drug must be administered to a group of volunteers and a placebo given to a control group in the same area where the virus is spreading to see if it works. Beijing-based Sinovac Biotech, which developed one of the vaccines being tested, has told AFP that it is looking to carry out the final stage of its trial abroad because China does not have a large enough coronavirus cluster. Experts say it will take at least 12 to 18 months to develop an effective vaccine, possibly even longer. prw/amj
schema:headline	China has fifth virus vaccine in human trial: official
schema:mentions	18 Months Agence France-Presse Sinovac Biotech Pipeline transport Virus Vaccine China Severe acute respiratory syndrome coronavirus 2 Placebo-controlled study Treatment and control groups National Health Commission
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-05-15 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	79 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software